Epstein Secrets

nominate Thomas L. Kirsch II for the 7th U.S. Circuit Court of Appeals Wednesday to fill the seat left open" after Barrett's expected confirmation. Kirsch currently serves as the US Attorney for the Northern District of Indiana. Murkowski Signals She Will Vote Against Barrett. Politico (10/22, Everett

e AP (10/22, Marchione) reports that the "antiviral medicine given to hospitalized patients through an IV," being marketed by manufacturer Gilead as Veklury, "cut the time to recovery by five days - from 15 days to 10 on average - in a large study led by the U.S. National Institutes of Health." The drug

o nominate Thomas L. Kirsch H for the 7th U.S. Circuit Court of Appeals Wednesday to fill the seat left open" after Barrett's expected confirmation. Kirsch currently serves as the US Attorney for the Northern District of Indiana. Murkowski Signals She Will Vote Against Barrett. Politico <https://www.po

63> (10/22, Marchione) reports that the "antiviral medicine given to hospitalized patients through an IV," being marketed by manufacturer Gilead as Veklury, "cut the time to recovery by five days - from 15 days to 10 on average — in a large study led by the U.S. National Institutes of Health." The drug

nominate Thomas L. Kirsch II for the 7th U.S. Circuit Court of Appeals Wednesday to fill the seat left open" after Barrett's expected confirmation. Kirsch currently serves as the US Attorney for the Northern District of Indiana. Murkowski Signals She Will Vote Against Barrett. Politico (10/22, Everett

e AP (10/22, Marchione) reports that the "antiviral medicine given to hospitalized patients through an IV," being marketed by manufacturer Gilead as Veklury, "cut the time to recovery by five days - from 15 days to 10 on average - in a large study led by the U.S. National Institutes of Health." The drug